Evaluation of Neuroinflamation of SAH

Bezmialem Vakif University54 enrolled

Overview

The investigators are planning that can these markers be used a predictive marker at SAH and for this aim we will study both patiens' blood sample and their CT image.

An ideal marker which could be used clinically should meet numerous criteria, such as high sensitivity or the possibility of easy and quick assessment of its concentration in blood or blood plasma.The Fisher's scale presents an alternative for evaluating patients with subarachnoid hemorrhage . The investigator are going to evaluate both plasma markers and fishers scale at SAH.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Subarachnoid Hemorrhage, Aneurysmal

Interventions

Bezmialem VAkif Unv. Ethical boardDIAGNOSTIC_TEST

If ıs any trials not convenient to Helsinki Agrement about Human research rules

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Ruptured Subarachnoid Aneursym Exclusion Criteria: * without aneursymal sah * Patient's positive for rheumatoid factor and anti-CCP or with chronic inflammatory diseases (such as ankylosing spondylitis or rheumatoid arthritis), systemic diseases (such as hypercholesterolemia, hypertension, diabetes mellitus, myocardial infarction, stroke, peripheral artery disease), active infection, a history of term medication, trauma to the hip and smoking were excluded from the study.

Outcomes

Primary Outcomes

Diagnostic marker identification

Evaluation of the concentration levels of enflamation markers relation with Sur1 TRPM+ molecules, together with the values of global tests of coagulation system, may serve as a helpful SAH diagnostic marker.

Time frame: 24 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.